Paramount Global Statistics

Total Valuation

Ocugen has a market cap or net worth of MXN 5.35 billion. The enterprise value is 5.46 billion.

Market Cap	5.35B
Enterprise Value	5.46B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	292.30M
Shares Outstanding	n/a
Shares Change (YoY)	+12.21%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	287.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	59.71
PB Ratio	93.01
P/TBV Ratio	93.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.08
EV / Sales	61.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.54

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 10.75.

Current Ratio	1.83
Quick Ratio	1.50
Debt / Equity	10.75
Debt / EBITDA	n/a
Debt / FCF	-0.63
Interest Coverage	-21.75

Financial Efficiency

Return on equity (ROE) is -569.99% and return on invested capital (ROIC) is -116.04%.

Return on Equity (ROE)	-569.99%
Return on Assets (ROA)	-73.55%
Return on Invested Capital (ROIC)	-116.04%
Return on Capital Employed (ROCE)	-155.56%
Revenue Per Employee	943,704
Profits Per Employee	-11.31M
Employee Count	95
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.33%
50-Day Moving Average	19.62
200-Day Moving Average	16.94
Relative Strength Index (RSI)	39.89
Average Volume (20 Days)	518

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.97

Income Statement

In the last 12 months, Ocugen had revenue of MXN 89.65 million and -1.07 billion in losses. Loss per share was -3.73.

Revenue	89.65M
Gross Profit	-557.75M
Operating Income	-1.04B
Pretax Income	-1.07B
Net Income	-1.07B
EBITDA	-987.06M
EBIT	-1.04B
Loss Per Share	-3.73

Full Income Statement

Balance Sheet

The company has 509.42 million in cash and 618.98 million in debt, giving a net cash position of -109.57 million.

Cash & Cash Equivalents	509.42M
Total Debt	618.98M
Net Cash	-109.57M
Net Cash Per Share	n/a
Equity (Book Value)	57.56M
Book Value Per Share	0.20
Working Capital	280.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -975.40 million and capital expenditures -10.92 million, giving a free cash flow of -986.32 million.

Operating Cash Flow	-975.40M
Capital Expenditures	-10.92M
Free Cash Flow	-986.32M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,165.08%
Pretax Margin	-1,197.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.21%
Shareholder Yield	n/a
Earnings Yield	-20.08%
FCF Yield	-18.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -9.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.42
Piotroski F-Score	2